Abstract
Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter
Original language | English |
---|---|
Pages (from-to) | 60-66 |
Number of pages | 7 |
Journal | Catheterization and Cardiovascular Interventions |
Volume | 76 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jul 1 2010 |
Keywords
- Coronary arteries
- Drug-eluting stents
- Lumen loss
- Small vessels
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
- Medicine(all)